Searched for
LUPIN NEWS
Stocks in news: IndiGo, Sammaan Capital, Bharti Airtel, GRSE, CoforgeMarkets experienced a sharp sell-off on Monday's monthly expiry day, with the Nifty closing near 22,331. Key companies like IndiGo, Bharti ...01 Apr, 2026, 06.11 AM IST- Lupin gets USFDA nod for biosimilar drugLupin gets USFDA approval for Armlupeg, a biosimilar to Neulasta, to treat neutropenia in cancer patients. The drug will be manufactured at...01 Dec, 2025, 12.02 PM IST
- Lupin shares up 1.02% as Nifty gainsA total of 5,804 shares changed hands on the counter till time (IST).17 Sep, 2024, 10.51 AM IST
- Share price of Lupin falls as Nifty strengthensA total of 9,229 shares changed hands on the counter till 11:57AM (IST).02 Sep, 2024, 11.57 AM IST
- Lupin divests women's health specialty business in US to Evofem Biosciences for nearly $84 mnLupin announced the sale of its US commercial women’s health specialty business, focusing on Solosec, to Evofem Biosciences. Solosec, an FD...15 Jul, 2024, 07.05 PM IST
- Lupin enters CDMO business, names Abdelaziz Toumi as CEO of new subsidiaryLupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development ...17 Jun, 2024, 07.53 PM IST
- Lupin Season 4 Update: Creator George Kay talks about next season; Here are the details"Lupin," which debuted on Netflix in 2021, has garnered a dedicated following, thanks to its gripping storyline and outstanding performance...16 Oct, 2023, 02.01 AM IST
- Lupin skids as failed USFDA specifications lead to recalls of 2 drugsThe company’s scrip fell to a low of Rs 937.15 as against Rs 951.80 at previous close on the National Stock Exchange.17 Jan, 2022, 10.26 AM IST
- Lupin Q2 results: Firms posts Rs 2,095 crore loss due to one-off impairmentsDuring the quarter, the company booked a provision of Rs 1879.6 crore towards litigation and settlement related to diabetic drug Glumetza c...28 Oct, 2021, 12.16 PM IST
- Lupin gains 1% on tentative USFDA nod to generic BrexpiprazoleAt 09:30 hours (IST), Lupin’s shares traded at Rs 957.70 on the National Stock Exchange, up 1.11% from previous close.07 Oct, 2021, 11.05 AM IST
- Licence to sell cancer drug biggest opportunity for Dr Reddy’s in US market: Nirmal Bang‘On a very conservative basis, the drug can add about $300 million to their sales in FY23-FY24.’18 Sep, 2020, 11.44 AM IST
- Lupin expects single digit sales growth this fiscalThe drug maker reported negative growth in 2017-18 for the first time in a decade, with net sales dropping to Rs 15,560 crore, a decline of...17 Jun, 2018, 11.01 AM IST
- Lupin launches generic insomnia drug in USDrug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.05 Apr, 2016, 02.34 PM IST
- Lupin, Unichem Laboratories among global companies fined by European CommissionAs per the European Commission Anti-trust ruling, Lupin has been fined 40 million euros, while Unichem Laboratories 13.96 million euros.10 Jul, 2014, 04.22 AM IST
- Lupin relentlessly compounding at 17-18%: Angel BrokingIt is relentlessly compounding at 17-18%, which is a healthy figure and more importantly there is a talk of some inorganic development in L...01 Aug, 2012, 11.10 AM IST
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning tradeShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...24 Aug, 2011, 11.06 AM IST
- Lupin files second suit against RanbaxyMumbai-based drugmaker Lupin has filed a second suit in the US against Ranbaxy Laboratories to prevent the country’s largest drugmaker from...06 Apr, 2011, 05.02 AM IST
Load More
